title: Reactive arthritis.
abstract: ReA consists of sterile axial or peripheral articular inflammation,enthesitis, and extra-articular manifestations. Most patients are HLA-B27 positive, although determining the B27 status of an individual patient is irrelevant. Exposure to specific bacterial antigens is usually the inciting factor. Diagnosis usually can be made by clinical examination and history. The current standard therapy is NSAIDs and physiotherapy, but molecular biologic treatment may ultimately become the mainstay in recalcitrant and severe ReA.
authors.affiliation: Division of Rheumatology, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, MEB484, PO Box 19, New Brunswick, NJ 08903-0019, USA.
authors.forename: Danielle Lauren
authors.initials: DL
authors.lastname: Petersel
authors.forename: Leonard H
authors.initials: LH
authors.lastname: Sigal
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D016918:Arthritis, Reactive / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D001424:Bacterial Infections / Q000150:complications; D003937:Diagnosis, Differential; D006801:Humans; D000091402:Prohibitins
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; C000717331:PHB2 protein, human; D000091402:Prohibitins